Prof. Andrea Alimonti, head of the Molecular Oncology at the Institute of Oncology Research and full professor at the University of the Italian-​Switzerland, the University of Padova, and the ETH Zurich visited Tes Pharma on the 18th May for a seminar on "Druggable Drivers of Castration Resistance in Prostate Cancer" and for discussions regarding potential future collaborations on the study of novel oncology targets.